PWA
BIIB icon

Pitcairn Wealth Advisors’s Biogen BIIB Stock Holding History

Pitcairn Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$650K Buy
3,010
+313
+12% +$59.9K 0.07% 151
2026
Q1 		$475K Buy
2,697
+132
+5% +$24.3K 0.04% 187
2025
Q4 		$451K Buy
+2,565
New +$419K 0.04% 192

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pitcairn Wealth Advisors's BIIB Position: Q2 2026 in Review

Pitcairn Wealth Advisors increased its Biogen (BIIB) stake by 12% in Q2 2026, buying an estimated $59.9K and bringing the position to 3,010 shares worth $650K. The position accounts for 0.07% of the portfolio, ranked #151.

Pitcairn Wealth Advisors first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,040 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Pitcairn Wealth Advisors held 3,010 shares of Biogen worth $650K as of Q2 2026.
  • Pitcairn Wealth Advisors bought 313 Biogen shares in Q2 2026, an estimated $59.9K.
  • Biogen made up 0.07% of Pitcairn Wealth Advisors's portfolio in Q2 2026, its #151 holding.
  • Pitcairn Wealth Advisors first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 1,040 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Pitcairn Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.